Acute Effects of Meteorological Factors and Air Pollution on Cardiovascular Health
Condition(s) studied
Investigational drug(s) / intervention(s)
NOT: This retrospective cohort study involves no new interventions. It analyzes existing health data collected from subjects exposed to varying atmospheric conditions to assess impacts on health outcomes.
Study summary
The goal of this observational study is to analyze the acute effects of meteorological factors and air pollution on cardiovascular system. The main question it aims to answer is:
1. How do meteorological factors and air pollution affect cardiovascular system?
2. What is the interaction between meteorological factors and air pollution on cardiovascular system?
Participants will:
1. Provide their health data obtained in physical examination, including but not limited to blood pressure, blood routine, urine routine and B-ultrasound.
2. agree that the research team will use their personal identification number, gender, age, education level and other information for statistical analysis of the data.
Eligibility
Primary outcome measure(s)
- Troponin — The troponin data were tested at baseline 3 months before exposure tometeorological factors or air pollution, and followed up for 1 year and 2 years after exposure.
Troponin data were obtained by blood biochemical detection data recorded in the diagnosis and treatment system, with unit of µg/L. - Blood pressure — The blood pressure data were tested at baseline 3 months before exposure tometeorological factors or air pollution, and followed up for 1 year and 2 years after exposure.
Blood pressure data were obtained from the diagnosis and treatment record system and analyzed by standard sphygmomanometer, with unit of mmHg.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| MingWei Wang | Hanzhou | Zhejiang | Recruiting |
More The Affiliated Hospital of Hangzhou Normal University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06663267 on ClinicalTrials.gov ↗ ← All trials in China